PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...
PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...
Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...
PhaseV's Adaptive Clinical Trials Platform Will Support the Gastrointestinal CRO in Addressing a Wide Range of GI-Related Conditions The collaboration has the potential to accelerate the ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results